Clinical trial
A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in…
NCT00124735 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00124735 |
|---|---|
| Title | A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797) |
| Official title | An Open-label, Randomized, Phase IIIB, Multicenter Trial to Evaluate the Pharmacodynamic Parameters of Intubation Bolus, and Bolus and Infusion Maintenance Doses of Zemuron® in Pediatric and Adolescent Subjects |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anesthesia |
| Intervention type | Drug |
| Interventions | Rocuronium bolus maintenance, rocuronium continuous infusion maintenance |
| Enrollment | 149 |
| Start date | Oct 1, 2004 |
| Primary completion | Aug 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jul 28, 2005 |
| Last update posted | Aug 24, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: